SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-23-031391
Filing Date
2023-11-13
Accepted
2023-11-13 08:00:53
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20230930_10q.htm   iXBRL 10-Q 835691
2 EXHIBIT 10.1 ex_593048.htm EX-10.1 29790
3 EXHIBIT 31.1 ex_560448.htm EX-31.1 13422
4 EXHIBIT 31.2 ex_560449.htm EX-31.2 13255
5 EXHIBIT 32.1 ex_560450.htm EX-32.1 6701
6 EXHIBIT 32.2 ex_560451.htm EX-32.2 6780
12 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-23-031391.txt   3821059

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20230930.xsd EX-101.SCH 37274
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20230930_cal.xml EX-101.CAL 24275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20230930_def.xml EX-101.DEF 243116
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20230930_lab.xml EX-101.LAB 213531
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20230930_pre.xml EX-101.PRE 259308
46 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20230930_10q_htm.xml XML 492569
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671997 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 231395234
SIC: 2834 Pharmaceutical Preparations